Fountain Hills, ARIZONA1 Active Studies

Hidradenitis Suppurativa Clinical Trials in Fountain Hills, ARIZONA

Find 1 actively recruiting hidradenitis suppurativa clinical trials in Fountain Hills, ARIZONA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
1,328
Enrolling

Recruiting Hidradenitis Suppurativa Studies in Fountain Hills

About Hidradenitis Suppurativa Clinical Trials in Fountain Hills

Hidradenitis suppurativa is a chronic skin condition causing painful lumps under the skin, typically in areas where skin rubs together. It can lead to tunnels under the skin and scarring. Treatment includes antibiotics, biologics, and surgical interventions.

There are currently 1 hidradenitis suppurativa clinical trials recruiting participants in Fountain Hills, ARIZONA. These studies are seeking a combined 1,328 participants. Research is being sponsored by AbbVie. Clinical trial participation is free and participants receive study-related medical care at no cost.

Hidradenitis Suppurativa Clinical Trials in Fountain Hills — FAQ

Are there hidradenitis suppurativa clinical trials in Fountain Hills?

Yes, there are 1 hidradenitis suppurativa clinical trials currently recruiting in Fountain Hills, ARIZONA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Fountain Hills?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fountain Hills research site will contact you about next steps.

Are clinical trials in Fountain Hills free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fountain Hills studies also compensate for your time and travel.

What hidradenitis suppurativa treatments are being tested?

The 1 active trials in Fountain Hills are testing new therapies including novel drugs, biologics, and treatment approaches for hidradenitis suppurativa.

Data updated March 2, 2026 from ClinicalTrials.gov